Sign in Sign up for free

Neuland Laboratories Payout ratio

What is the Payout ratio of Neuland Laboratories?

The Payout ratio of Neuland Laboratories Limited is 71.63%

What is the definition of Payout ratio?



Payout ratio is the fraction of earnings paid in dividends to stockholders.

ttm (trailing twelve months)

The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.

Payout ratio of companies in the Health Care sector on BSE compared to Neuland Laboratories

What does Neuland Laboratories do?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Companies with payout ratio similar to Neuland Laboratories